A comprehensive study to delineate the role of an extracellular vesicle-associated microRNA-29a in chronic

Subhash Chand1, Austin Gowen1, Mason Savine1

  • 1Department of Anesthesiology, University of Nebraska Medical Center (UNMC), Omaha, Nebraska, USA.

Insights

Brain-derived extracellular vesicle microRNA-29a-3p increases with chronic methamphetamine exposure, driving inflammation and neuronal damage. This microRNA may serve as a biomarker for methamphetamine use disorder.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Extracellular vesicles (EVs) mediate intercellular communication through their cargo.
  • Chronic methamphetamine (MA) exposure causes significant neuroinflammation and synaptodendritic damage.
  • MicroRNAs (miRNAs) are key regulators of gene expression and cellular processes.

Purpose of the Study:

  • To investigate the role of brain-derived EV miRNA, specifically miR-29a-3p, in chronic methamphetamine use disorder (MUD).
  • To determine if miR-29a-3p levels correlate with drug-seeking behavior and neuroinflammation.
  • To evaluate the potential of EV-miR29a as a biomarker for neuronal damage in MUD.

Main Methods:

  • Utilized non-human primate and rodent models for chronic MA exposure.
  • Measured miR-29a-3p levels in brain-derived EVs during MA self-administration and reinstatement.
  • Analyzed EV composition and treated animals with ibudilast (AV411).
  • Assessed plasma EV-miR29a in human subjects with MUD.

Main Results:

  • Chronic MA exposure significantly increased brain-derived EV miR-29a-3p levels in animal models.
  • Elevated miR-29a-3p correlated with drug-seeking behavior and MA-induced inflammation and synaptodendritic damage.
  • Ibudilast treatment reduced miR-29a-3p, inflammation, and neuronal injury.
  • Plasma EV-miR29a levels were elevated in human MUD subjects, indicating potential as a biomarker.

Conclusions:

  • EV-associated miR-29a-3p plays a critical role in mediating MA-induced neuroinflammation and synaptodendritic damage.
  • miR-29a-3p is a potential blood-based biomarker for detecting chronic inflammation and synaptic damage in MUD.
  • Targeting EV-miR29a may offer therapeutic strategies for MUD.